Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

SCAI Therapeutics

Request full access

The dating app that does it all - make friends, meet people, or find a date

Seoul, South KoreaFounded 2019Dating

About SCAI Therapeutics

Scai Therapeutics operates in the biotechnology sector, focusing on the discovery and development of innovative cancer treatments. The company leverages artificial intelligence (AI) and machine learning to identify and develop novel drug candidates, aiming to improve the efficiency and success rate of cancer drug discovery. Scai Therapeutics primarily serves pharmaceutical companies and research institutions, providing them with advanced tools and insights to expedite their drug development processes. The company operates on a B2B (business-to-business) model, generating revenue through partnerships, licensing agreements, and collaborative research projects. By integrating cutting-edge technology with deep scientific expertise, Scai Therapeutics aims to transform the landscape of cancer treatment and bring new hope to patients worldwide.

Source: Dealroom company data

At a glance

Status
Operational
Employees
9
Open positions
None listed
Dealroom signal
22.7/100
Industry
Dating
Client focus
B2B

Funding history

3 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES COther financing Jul 2026 $11M $44M BonAngels · SolidX ↗
SERIES BOther financing Jul 2021 $26M $105M LifeCare Partners · IMM Investment · Stonebridge Ventures —
Showing the latest 2 of 3 recorded eventsBook a demo for the full funding history →

Growth signals

SCAI Therapeutics website traffic

Latest recorded traffic for SCAI Therapeutics is 3.2K monthly website visits, up 247.8% over the last three months. SCAI Therapeutics's team grew 0% over the past year.

Latest monthly visits3.2K 3-month web change+247.8% 1-year team growth0%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

SCAI Therapeutics in the Seoul ecosystem

Live from Dealroom

The SCAI Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

6 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A3 investors entered at this stage

  • LifeCare Partners
  • IMM Investment
  • Stonebridge Ventures

Series B and later2 investors entered at this stage

  • BonAngels
  • SolidX

Other known investors1 additional known investor

  • HB Investment
Team profiled 1 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
2 countries with
team presence
🇰🇷 South Korea66.7%
🇯🇵 Japan33.3%
2 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about SCAI Therapeutics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See SCAI Therapeutics’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.